| Financial Year |
March 31 2023 |
| Monetary Funds |
310,917,258.35 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
111,486,425.20 |
| Advances to Suppliers |
11,128,912.11 |
| Other Receivables |
1,730,650.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
76,775,119.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,346,764.37 |
| Total Current Assets |
515,848,839.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,423,441,739.72 |
| Under-construction Projects |
26,790,368.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
390,891,912.12 |
| R&D expenses |
-- |
| Goodwill |
11,833,238.83 |
| Long-Term Deferred and Prepaid Expenses |
5,368,076.06 |
| Deferred Income Tax Assets |
20,866,481.30 |
| Other Non-Current Assets |
14,354,383.17 |
| Sub-Total of Non-Current Assets |
1,897,250,215.89 |
| Total Assets |
2,413,099,055.00 |
| Short-Term Loans |
728,789,502.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
131,514,785.00 |
| Accounts Payable |
160,400,178.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
52,001,419.01 |
| Taxes Payable |
20,588,292.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
69,122,539.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
59,877,141.26 |
| Other Current Liabilities |
216,948.80 |
| Sub-Total of Current Liabilities |
1,224,368,323.17 |
| Long-term Loans |
9,006,780.82 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
81,839,563.19 |
| Total Liabilities |
1,306,207,886.36 |
| Paid-In Capital(Or Share Stock) |
440,000,000.00 |
| Capital Surplus |
294,040,062.86 |
| Surplus Reserve |
56,639,078.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
308,136,651.61 |
| Minority Stockholder's Interest |
8,075,375.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,098,815,792.83 |
| Owner's Equity（Stockholder's Equity） |
1,106,891,168.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,413,099,055.00 |
